Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-02-07 Sale |
2022-02-09 5:43 pm |
Epizyme Inc. | EPZM | Beaulieu Joseph Corporate Controller |
222 | $1.5 | $333 | 28,632 (Direct) |
View |
| 2022-02-07 Sale |
2022-02-09 5:40 pm |
Epizyme Inc. | EPZM | Agarwal Shefali See Remarks |
1,058 | $1.5 | $1,587 | 156,385 (Direct) |
View |
| 2022-02-02 Sale |
2022-02-04 4:15 pm |
Epizyme Inc. | EPZM | Agarwal Shefali See Remarks |
2,639 | $1.37 | $3,615 | 157,443 (Direct) |
View |
| 2022-02-02 Sale |
2022-02-04 4:15 pm |
Epizyme Inc. | EPZM | Kutok Jeffery Chief Scientific Officer |
2,556 | $1.37 | $3,502 | 97,304 (Direct) |
View |
| 2022-02-02 Sale |
2022-02-04 4:15 pm |
Epizyme Inc. | EPZM | Beaulieu Joseph Corporate Controller |
687 | $1.37 | $941 | 28,854 (Direct) |
View |
| 2022-01-31 Purchase |
2022-02-01 4:17 pm |
Epizyme Inc. | EPZM | Legorreta Pablo G. RP Management LLC RPI Finance Trust Director 10% Owner |
22,666,667 | $1.5 | $34,000,001 | 31,930,464 (Indirect Direct) |
View |
| 2022-01-26 Sale |
2022-01-28 4:15 pm |
Epizyme Inc. | EPZM | Agarwal Shefali See Remarks |
2,922 | $2.02 | $5,902 | 160,082 (Direct) |
View |
| 2021-12-06 Sale |
2021-12-07 7:03 pm |
Epizyme Inc. | EPZM | Agarwal Shefali See Remarks |
1,780 | $2.93 | $5,215 | 163,004 (Direct) |
View |
| 2021-04-05 Sale |
2021-04-07 06:15 am |
Epizyme Inc. | EPZM | Kutok Jeffery Chief Scientific Officer |
2,029 | $8.8 | $17,855 | 54,028 (Direct) |
View |
| 2021-03-25 Purchase |
2021-03-29 4:30 pm |
Epizyme Inc. | EPZM | MOTT DAVID M Director |
62,717 | $7.9739 | $500,100 | 257,859 (Indirect Direct) |
View |
| 2021-03-25 Sale |
2021-03-29 4:30 pm |
Epizyme Inc. | EPZM | Bazemore Robert B President & CEO |
10,328 | $7.85 | $81,075 | 322,626 (Direct) |
View |
| 2021-02-04 Sale |
2021-02-05 4:41 pm |
Epizyme Inc. | EPZM | Bazemore Robert B President & CEO |
3,890 | $11.21 | $43,607 | 331,977 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2022-02-09 4:30 pm |
N/A N/A |
Epizyme Inc. | EPZM | Royalty Pharma Investments 2019 ICAV Director 10% Owner |
0 | $0 | 22,666,667 (Direct) |
View |
| 2022-02-02 Option Award |
2022-02-04 4:15 pm |
N/A 2032-02-01 |
Epizyme Inc. | EPZM | Bogle Grant C. See Remarks |
505,000 | $0 | 600,560 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-04 4:20 pm |
N/A N/A |
Epizyme Inc. | EPZM | MOTT DAVID M Director |
9,500 | $2.5 | 285,644 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-04 4:17 pm |
N/A N/A |
Epizyme Inc. | EPZM | Conroy Kevin T Director |
6,000 | $2.5 | 30,077 (Direct) |
View |
| 2021-11-16 Option Award |
2021-11-18 08:22 am |
N/A 2031-11-15 |
Epizyme Inc. | EPZM | BEVERIDGE ROY A Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-11-16 Option Award |
2021-11-18 08:20 am |
N/A 2031-11-15 |
Epizyme Inc. | EPZM | Stuckley Carol Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-09-30 Option Award |
2021-10-01 4:30 pm |
N/A N/A |
Epizyme Inc. | EPZM | MOTT DAVID M Director |
4,640 | $5.12 | 276,144 (Direct) |
View |
| 2021-09-30 Option Award |
2021-10-01 4:30 pm |
N/A N/A |
Epizyme Inc. | EPZM | Conroy Kevin T Director |
2,930 | $5.12 | 24,077 (Direct) |
View |
| 2021-08-16 Option Award |
2021-08-18 08:09 am |
N/A 2031-08-15 |
Epizyme Inc. | EPZM | Kutok Jeffery Chief Scientific Officer |
264,493 | $0 | 318,521 (Direct) |
View |
| 2021-08-16 Option Award |
2021-08-18 08:07 am |
N/A 2031-08-15 |
Epizyme Inc. | EPZM | Beaulieu Joseph Corporate Controller |
37,083 | $0 | 50,514 (Direct) |
View |
| 2021-08-16 Option Award |
2021-08-18 08:02 am |
N/A 2031-08-15 |
Epizyme Inc. | EPZM | Ros Matthew See Remarks |
162,303 | $0 | 245,491 (Direct) |
View |
| 2021-08-16 Option Award |
2021-08-18 08:02 am |
N/A 2031-08-15 |
Epizyme Inc. | EPZM | Bogle Grant C. See Remarks |
505,000 | $0 | 513,060 (Direct) |
View |
| 2021-08-16 Option Award |
2021-08-18 08:00 am |
N/A 2031-08-15 |
Epizyme Inc. | EPZM | Agarwal Shefali See Remarks |
341,436 | $0 | 445,777 (Direct) |
View |
| 2021-06-30 Option Award |
2021-07-01 4:15 pm |
N/A N/A |
Epizyme Inc. | EPZM | Conroy Kevin T Director |
1,805 | $8.31 | 21,147 (Direct) |
View |
| 2021-06-30 Option Award |
2021-07-01 4:15 pm |
N/A N/A |
Epizyme Inc. | EPZM | MOTT DAVID M Director |
2,858 | $8.31 | 271,504 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-15 5:14 pm |
2022-06-11 N/A |
Epizyme Inc. | EPZM | Legorreta Pablo G. RP Management LLC RPI Finance Trust Director 10% Owner |
8,060 | $0 | 9,263,797 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-15 5:14 pm |
2022-06-11 2031-06-11 |
Epizyme Inc. | EPZM | Legorreta Pablo G. RP Management LLC RPI Finance Trust Director 10% Owner |
40,559 | $8.53 | 9,263,797 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-15 4:41 pm |
N/A 2031-06-10 |
Epizyme Inc. | EPZM | BATE KENNETH Director |
48,619 | $0 | 48,619 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-15 4:40 pm |
N/A 2031-06-10 |
Epizyme Inc. | EPZM | Bogle Grant C. Director |
48,619 | $0 | 48,619 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-15 4:38 pm |
N/A 2031-06-10 |
Epizyme Inc. | EPZM | Giordano Michael F Director |
48,619 | $0 | 48,619 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-15 4:37 pm |
N/A 2031-06-10 |
Epizyme Inc. | EPZM | Allen Andrew R Director |
48,619 | $0 | 61,119 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-15 4:35 pm |
N/A 2031-06-10 |
Epizyme Inc. | EPZM | MOTT DAVID M Director |
48,619 | $0 | 309,205 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-15 4:35 pm |
N/A 2031-06-10 |
Epizyme Inc. | EPZM | Conroy Kevin T Director |
48,619 | $0 | 59,901 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-15 4:35 pm |
N/A 2031-06-10 |
Epizyme Inc. | EPZM | GOLDFISCHER CARL Director |
48,619 | $0 | 3,434,570 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-15 4:32 pm |
N/A 2031-06-10 |
Epizyme Inc. | EPZM | Richon Victoria Director |
48,619 | $0 | 54,173 (Direct) |
View |
| 2021-03-31 Option Award |
2021-04-01 7:00 pm |
N/A N/A |
Epizyme Inc. | EPZM | Conroy Kevin T Director |
1,723 | $8.71 | 11,282 (Direct) |
View |
| 2021-03-31 Option Award |
2021-04-01 7:00 pm |
N/A N/A |
Epizyme Inc. | EPZM | MOTT DAVID M Director |
2,727 | $8.71 | 260,586 (Direct) |
View |